AI-Driven Computational Chemist — Pre-Programs (Hybrid)

AQEMIA is building AI-driven drug discovery workflows, and this role is key to scaling pre-program screening. You will own end-to-end QEMI virtual screening and hit expansion campaigns, including structure selection and target preparation, coordinating with compute and engineering teams to ensure high-quality, reproducible results.

Within 12 months, you will help standardize a resilient screening workflow to accelerate hit discovery across programs, contributing to platform and product

#J-18808-Ljbffr…